SC 13G Filing

Company

Cellectar Biosciences, Inc.

Filed

June 12, 2020

Accession Number

0000919574-20-004101

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →